Literature DB >> 15127962

Pharmacist involvement in antimicrobial use at rural community hospitals in four Western states.

Kurt B Stevenson1, Matthew Samore, James Barbera, Elizabeth Hannah, James W Moore, Julie L Gerberding, Peter Houck.   

Abstract

PURPOSE: Pharmacist involvement in antimicrobial use at small rural hospitals in four Western states was studied.
METHODS: Surveys were mailed in July 2000 to hospitals with a daily patient census of <150 in Idaho, Nevada, Utah, and eastern Washington.
RESULTS: Seventy-seven (77%) of 100 hospitals returned completed surveys. Only 5% of the hospitals had onsite pharmacists 24 hours per day. An onsite pharmacist was present for a median of 26 hours per week in hospitals without 24-hour pharmacist coverage (range, 0-116 hr/wk). Many hospitals (71%) had policies for monitoring or controlling antimicrobial use, but only 28% had a system capable of monitoring compliance with such policies. Few hospitals had systems for recommending changes in antimicrobial selection on the basis of susceptibility test results (27%) or for monitoring physician compliance with dosage recommendations by pharmacists (21%). Onsite pharmacist hours were significantly associated with pharmacists being involved in the initial ordering of antibiotics and providing active oversight of antimicrobial use. There was a negative correlation between onsite pharmacist hours and use of third-generation cephalosporins and carbapenems.
CONCLUSION: A survey showed that rural hospital pharmacists in four Western states spent relatively little time monitoring and influencing antimicrobial prescribing.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15127962     DOI: 10.1093/ajhp/61.8.787

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  1 in total

1.  Pharmacist interventions for prophylactic antibiotic use in urological inpatients undergoing clean or clean-contaminated operations in a Chinese hospital.

Authors:  Hai-Xia Zhang; Xin Li; Hai-Qin Huo; Pei Liang; Jin-Ping Zhang; Wei-Hong Ge
Journal:  PLoS One       Date:  2014-02-25       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.